RET Rearrangement as a Predictor of Unresponsiveness to Immunotherapy in Non-Small Cell Lung Cancer: Report of Two Cases with Review of the Literature

Patients with epidermal growth factor receptor and anaplastic lymphoma kinase positive non-small cell lung cancer (NSCLC) generally respond poorly to treatment with immune checkpoint inhibitors such as anti-programmed cell death-1 (PD-1) or anti-programmed cell death ligand-1 (PD-L1) given with or w...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncol Ther
Huvudupphovsmän: Baglivo, Sara, Ludovini, Vienna, Moretti, Riccardo, Bellezza, Guido, Sidoni, Angelo, Roila, Fausto, Metro, Giulio
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Healthcare 2020
Ämnen:
Case Series
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7683679/
https://ncbi.nlm.nih.gov/pubmed/32700042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40487-020-00116-2
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk